Three cases-one for the colon, a second in cardiology, and a third addressing the liver-will serve as the playing fields for this year’s Workstation Face-Off. Seven companies will go head to head Wednesday May 19 from 3:30 to 6 p.m. with luminaries putting their workstations through carefully choreographed steps.
Three cases-one for the colon, a second in cardiology, and a third addressing the liver-will serve as the playing fields for this year’s Workstation Face-Off. Seven companies will go head to head Wednesday May 19 from 3:30 to 6 p.m. with luminaries putting their workstations through carefully choreographed steps.
Vital Images will bring three physician-customers to champion their product; GE Healthcare will bring two . Philips, Siemens, Carestream, TeraRecon, and Ziosoft will each field just one operator. All operators will follow exactly the same instructions, demonstrating workflow and image quality on their respective workstations, all within the same four-minute time frame for each case.
Case 1 – Screening for colon polyps:
Case 2 – Aortic valvular stenosis as part of a preoperative evaluation:
Case 3 – Evaluation of a patient with metastatic cholangiocarcinoma on experimental treatment:
Rules of engagement prohibit the use of prerendering.
“No matter how fast you can switch from screen to screen to pick up on presaved views, the sophisticated audience can see what you are doing,” the rules advise.
If Face-Off moderator Dr. Geoffrey Rubin does as he has in the past, he will remind operators to fully magnify and zoom in on findings, a rule often overlooked under the time constraints of the demonstrations, time constraints that have been, and will be again this year, strictly enforced.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.